TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

SANALUZ

Infectious DiseaseMetabolic
Generics

SANALUZ is a generic drug manufacturer focused on Infectious Disease, Metabolic.

1964
Since
5
Drugs
-
Trials
225
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

OXYCODONE AND ACETAMINOPHEN 2026-01-12
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2026-01-08
Labeling
OXYCODONE AND ACETAMINOPHEN 2026-01-06
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 50%
1 drugs
Metabolic 50%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Merck big-pharma
Infectious Disease, Metabolic
Johnson & Johnson big-pharma
Infectious Disease, Metabolic
Sanofi big-pharma
Metabolic, Infectious Disease
B BRAUN specialty
Infectious Disease, Metabolic
KING PHARMS LLC big-pharma
Infectious Disease, Metabolic